Ticker
AKBACompany Name
AKEBIA THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Net Cash Flow - Operations | Operating Cash Flow Margin | Revenues |
---|---|---|---|
6/30/2025 | $ -2.4M | -1.18% | $ 203.73M |
3/31/2025 | $ -34.81M | -18.83% | $ 184.91M |
12/31/2024 | $ -40.66M | -25.38% | $ 160.18M |
9/30/2024 | $ -38.5M | -22.66% | $ 169.88M |
6/30/2024 | $ -38.97M | -22.33% | $ 174.5M |
3/31/2024 | $ -25.28M | -13.5% | $ 187.22M |
12/31/2023 | $ -23.38M | -12.02% | $ 194.62M |
9/30/2023 | $ -75.75M | -39.13% | $ 193.61M |
6/30/2023 | $ -34.78M | -17.35% | $ 200.53M |
3/31/2023 | $ -69.07M | -25.49% | $ 271.03M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
CF - Operations / Revenues
(=) OCF %
OCF % for AKEBIA THERAPEUTICS INC is calculated as follows: CF - Operations [ $ -171.74M ] / Revenues [ $ 308.16M ]
(=) OCF % [ -55.73% ]
Minimum
Dec 31, 2021
Maximum
Jun 30, 2025
Average
Median
filtered constituents | 3.25K |
---|---|
min | -57.27% |
max | 77.08% |
average | 14.31% |
median | 12.65% |
std | 21.13% |